Global Neuroprotective Drugs Market Professional Survey Report 2019

Published Date : 2019-10-08

Published By : Qy Research

Category : Pharma & Healthcare

No. of Pages : 102

Neuroprotective Drugs consist of medications that can be used to protect or preserve the neuronal cells of the brain from degeneration, stress, and injury, which can impair cognitive functions. 

The global Neuroprotective Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Neuroprotective Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Neuroprotective Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Neuroprotective Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Neuroprotective Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Genervon Biopharmaceuticals (Canada)
NeuroVive Pharmaceutical (Sweden)
Ceregene (USA)
BHRPharma (Thailand)
Neuren Pharmaceuticals (Australia)
Allon therapeutics (Canada)
Bionure Inc. (USA)
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Cholinesterase inhibitors
Anti-inflammatory
Others

Segment by Application
Alzheimer's disease
Parkinson's disease
Others

Table of Contents

Executive Summary
1 Industry Overview of Neuroprotective Drugs
1.1 Definition of Neuroprotective Drugs
1.2 Neuroprotective Drugs Segment by Type
1.2.1 Global Neuroprotective Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Cholinesterase inhibitors
1.2.3 Anti-inflammatory
1.2.4 Others
1.3 Neuroprotective Drugs Segment by Applications
1.3.1 Global Neuroprotective Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Alzheimer's disease
1.3.3 Parkinson's disease
1.3.4 Others
1.4 Global Neuroprotective Drugs Overall Market
1.4.1 Global Neuroprotective Drugs Revenue (2014-2025)
1.4.2 Global Neuroprotective Drugs Production (2014-2025)
1.4.3 North America Neuroprotective Drugs Status and Prospect (2014-2025)
1.4.4 Europe Neuroprotective Drugs Status and Prospect (2014-2025)
1.4.5 China Neuroprotective Drugs Status and Prospect (2014-2025)
1.4.6 Japan Neuroprotective Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Neuroprotective Drugs Status and Prospect (2014-2025)
1.4.8 India Neuroprotective Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Neuroprotective Drugs
2.3 Manufacturing Process Analysis of Neuroprotective Drugs
2.4 Industry Chain Structure of Neuroprotective Drugs

3 Development and Manufacturing Plants Analysis of Neuroprotective Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Neuroprotective Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Neuroprotective Drugs
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Neuroprotective Drugs Production and Capacity Analysis
4.2 Neuroprotective Drugs Revenue Analysis
4.3 Neuroprotective Drugs Price Analysis
4.4 Market Concentration Degree

5 Neuroprotective Drugs Regional Market Analysis
5.1 Neuroprotective Drugs Production by Regions
5.1.1 Global Neuroprotective Drugs Production by Regions
5.1.2 Global Neuroprotective Drugs Revenue by Regions
5.2 Neuroprotective Drugs Consumption by Regions
5.3 North America Neuroprotective Drugs Market Analysis
5.3.1 North America Neuroprotective Drugs Production
5.3.2 North America Neuroprotective Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Neuroprotective Drugs Import and Export
5.4 Europe Neuroprotective Drugs Market Analysis
5.4.1 Europe Neuroprotective Drugs Production
5.4.2 Europe Neuroprotective Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Neuroprotective Drugs Import and Export
5.5 China Neuroprotective Drugs Market Analysis
5.5.1 China Neuroprotective Drugs Production
5.5.2 China Neuroprotective Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Neuroprotective Drugs Import and Export
5.6 Japan Neuroprotective Drugs Market Analysis
5.6.1 Japan Neuroprotective Drugs Production
5.6.2 Japan Neuroprotective Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Neuroprotective Drugs Import and Export
5.7 Southeast Asia Neuroprotective Drugs Market Analysis
5.7.1 Southeast Asia Neuroprotective Drugs Production
5.7.2 Southeast Asia Neuroprotective Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Neuroprotective Drugs Import and Export
5.8 India Neuroprotective Drugs Market Analysis
5.8.1 India Neuroprotective Drugs Production
5.8.2 India Neuroprotective Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Neuroprotective Drugs Import and Export

6 Neuroprotective Drugs Segment Market Analysis (by Type)
6.1 Global Neuroprotective Drugs Production by Type
6.2 Global Neuroprotective Drugs Revenue by Type
6.3 Neuroprotective Drugs Price by Type

7 Neuroprotective Drugs Segment Market Analysis (by Application)
7.1 Global Neuroprotective Drugs Consumption by Application
7.2 Global Neuroprotective Drugs Consumption Market Share by Application (2014-2019)

8 Neuroprotective Drugs Major Manufacturers Analysis
8.1 Genervon Biopharmaceuticals (Canada)
8.1.1 Genervon Biopharmaceuticals (Canada) Neuroprotective Drugs Production Sites and Area Served
8.1.2 Genervon Biopharmaceuticals (Canada) Product Introduction, Application and Specification
8.1.3 Genervon Biopharmaceuticals (Canada) Neuroprotective Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 NeuroVive Pharmaceutical (Sweden)
8.2.1 NeuroVive Pharmaceutical (Sweden) Neuroprotective Drugs Production Sites and Area Served
8.2.2 NeuroVive Pharmaceutical (Sweden) Product Introduction, Application and Specification
8.2.3 NeuroVive Pharmaceutical (Sweden) Neuroprotective Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Ceregene (USA)
8.3.1 Ceregene (USA) Neuroprotective Drugs Production Sites and Area Served
8.3.2 Ceregene (USA) Product Introduction, Application and Specification
8.3.3 Ceregene (USA) Neuroprotective Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 BHRPharma (Thailand)
8.4.1 BHRPharma (Thailand) Neuroprotective Drugs Production Sites and Area Served
8.4.2 BHRPharma (Thailand) Product Introduction, Application and Specification
8.4.3 BHRPharma (Thailand) Neuroprotective Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Neuren Pharmaceuticals (Australia)
8.5.1 Neuren Pharmaceuticals (Australia) Neuroprotective Drugs Production Sites and Area Served
8.5.2 Neuren Pharmaceuticals (Australia) Product Introduction, Application and Specification
8.5.3 Neuren Pharmaceuticals (Australia) Neuroprotective Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Allon therapeutics (Canada)
8.6.1 Allon therapeutics (Canada) Neuroprotective Drugs Production Sites and Area Served
8.6.2 Allon therapeutics (Canada) Product Introduction, Application and Specification
8.6.3 Allon therapeutics (Canada) Neuroprotective Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Bionure Inc. (USA)
8.7.1 Bionure Inc. (USA) Neuroprotective Drugs Production Sites and Area Served
8.7.2 Bionure Inc. (USA) Product Introduction, Application and Specification
8.7.3 Bionure Inc. (USA) Neuroprotective Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served

9 Development Trend of Analysis of Neuroprotective Drugs Market
9.1 Global Neuroprotective Drugs Market Trend Analysis
9.1.1 Global Neuroprotective Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Neuroprotective Drugs Regional Market Trend
9.2.1 North America Neuroprotective Drugs Forecast 2019-2025
9.2.2 Europe Neuroprotective Drugs Forecast 2019-2025
9.2.3 China Neuroprotective Drugs Forecast 2019-2025
9.2.4 Japan Neuroprotective Drugs Forecast 2019-2025
9.2.5 Southeast Asia Neuroprotective Drugs Forecast 2019-2025
9.2.6 India Neuroprotective Drugs Forecast 2019-2025
9.3 Neuroprotective Drugs Market Trend (Product Type)
9.4 Neuroprotective Drugs Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Neuroprotective Drugs Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer


List of Tables and Figures
Figure Picture of Neuroprotective Drugs
Table Global Neuroprotective Drugs Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Neuroprotective Drugs Production Market Share by Types in 2018
Figure Cholinesterase inhibitors Product Picture
Figure Anti-inflammatory Product Picture
Figure Others Product Picture
Table Global Neuroprotective Drugs Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Neuroprotective Drugs Consumption Market Share by Applications in 2018
Figure Alzheimer's disease
Figure Parkinson's disease
Figure Others
Figure Global Neuroprotective Drugs Revenue (Million USD) (2014-2025)
Figure Global Neuroprotective Drugs Production (K Units) (2014-2025)
Figure North America Neuroprotective Drugs Market Size (Million USD) (2014-2025)
Figure Europe Neuroprotective Drugs Market Size (Million USD) (2014-2025)
Figure China Neuroprotective Drugs Market Size (Million USD) (2014-2025)
Figure Japan Neuroprotective Drugs Market Size (Million USD) (2014-2025)
Figure Southeast Asia Neuroprotective Drugs Market Size (Million USD) (2014-2025)
Figure India Neuroprotective Drugs Market Size (Million USD) (2014-2025)
Table Neuroprotective Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Neuroprotective Drugs in 2018
Figure Manufacturing Process Analysis of Neuroprotective Drugs
Figure Industry Chain Structure of Neuroprotective Drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Neuroprotective Drugs Manufacturing Plants Distribution
Table Neuroprotective Drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Neuroprotective Drugs Capacity (K Units) of Major Manufacturers (2014-2019)
Table Neuroprotective Drugs Production (K Units) of Major Manufacturers (2014-2019)
Table Neuroprotective Drugs Production Market Share of Major Manufacturers (2014-2019)
Figure Neuroprotective Drugs Production Share by Manufacturers in 2018
Table Neuroprotective Drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Neuroprotective Drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure Neuroprotective Drugs Revenue Share by Manufacturers in 2018
Table Neuroprotective Drugs Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Neuroprotective Drugs Production by Regions 2014-2019 (K Units)
Table Global Neuroprotective Drugs Production Market Share by Regions 2014-2019
Figure Global Neuroprotective Drugs Production Market Share by Regions in 2018
Table Global Neuroprotective Drugs Revenue by Regions 2014-2019 (Million USD)
Table Global Neuroprotective Drugs Revenue Market Share by Regions 2014-2019
Figure Global Neuroprotective Drugs Revenue Market Share by Regions in 2018
Table Global Neuroprotective Drugs Consumption by Regions 2014-2019 (K Units)
Table Global Neuroprotective Drugs Consumption Market Share by Regions 2014-2019
Figure North America Neuroprotective Drugs Production Growth Rate 2014-2019 (K Units)
Figure North America Neuroprotective Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America Neuroprotective Drugs Production, Consumption Import and Export (K Units)
Figure Europe Neuroprotective Drugs Production Growth Rate 2014-2019 (K Units)
Figure Europe Neuroprotective Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Neuroprotective Drugs Production, Consumption Import and Export (K Units)
Figure China Neuroprotective Drugs Production Growth Rate 2014-2019 (K Units)
Figure China Neuroprotective Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China Neuroprotective Drugs Production, Consumption Import and Export (K Units)
Figure Japan Neuroprotective Drugs Production Growth Rate 2014-2019 (K Units)
Figure Japan Neuroprotective Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Neuroprotective Drugs Production, Consumption Import and Export (K Units)
Figure Southeast Asia Neuroprotective Drugs Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Neuroprotective Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Neuroprotective Drugs Production, Consumption Import and Export (K Units)
Figure India Neuroprotective Drugs Production Growth Rate 2014-2019 (K Units)
Figure India Neuroprotective Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table India Neuroprotective Drugs Production, Consumption Import and Export (K Units)
Figure Global Consumption Neuroprotective Drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) Neuroprotective Drugs Market Share by Application (2014-2019)
Table Genervon Biopharmaceuticals (Canada) Neuroprotective Drugs Production Sites and Area Served
Table Genervon Biopharmaceuticals (Canada) Neuroprotective Drugs Product Introduction, Application and Specification
Table Genervon Biopharmaceuticals (Canada) Neuroprotective Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Genervon Biopharmaceuticals (Canada) Neuroprotective Drugs Production Growth Rate (2014-2019)
Table Genervon Biopharmaceuticals (Canada) Neuroprotective Drugs Production Market Share (2014-2019)
Figure Genervon Biopharmaceuticals (Canada) Neuroprotective Drugs Revenue Market Share (2014-2019)
Table Genervon Biopharmaceuticals (Canada) Neuroprotective Drugs Main Business and Markets Served
Table NeuroVive Pharmaceutical (Sweden) Neuroprotective Drugs Production Sites and Area Served
Table NeuroVive Pharmaceutical (Sweden) Neuroprotective Drugs Product Introduction, Application and Specification
Table NeuroVive Pharmaceutical (Sweden) Neuroprotective Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table NeuroVive Pharmaceutical (Sweden) Neuroprotective Drugs Production Growth Rate (2014-2019)
Table NeuroVive Pharmaceutical (Sweden) Neuroprotective Drugs Production Market Share (2014-2019)
Figure NeuroVive Pharmaceutical (Sweden) Neuroprotective Drugs Revenue Market Share (2014-2019)
Table NeuroVive Pharmaceutical (Sweden) Neuroprotective Drugs Main Business and Markets Served
Table Ceregene (USA) Neuroprotective Drugs Production Sites and Area Served
Table Ceregene (USA) Neuroprotective Drugs Product Introduction, Application and Specification
Table Ceregene (USA) Neuroprotective Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Ceregene (USA) Neuroprotective Drugs Production Growth Rate (2014-2019)
Table Ceregene (USA) Neuroprotective Drugs Production Market Share (2014-2019)
Figure Ceregene (USA) Neuroprotective Drugs Revenue Market Share (2014-2019)
Table Ceregene (USA) Neuroprotective Drugs Main Business and Markets Served
Table BHRPharma (Thailand) Neuroprotective Drugs Production Sites and Area Served
Table BHRPharma (Thailand) Neuroprotective Drugs Product Introduction, Application and Specification
Table BHRPharma (Thailand) Neuroprotective Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table BHRPharma (Thailand) Neuroprotective Drugs Production Growth Rate (2014-2019)
Table BHRPharma (Thailand) Neuroprotective Drugs Production Market Share (2014-2019)
Figure BHRPharma (Thailand) Neuroprotective Drugs Revenue Market Share (2014-2019)
Table BHRPharma (Thailand) Neuroprotective Drugs Main Business and Markets Served
Table Neuren Pharmaceuticals (Australia) Neuroprotective Drugs Production Sites and Area Served
Table Neuren Pharmaceuticals (Australia) Neuroprotective Drugs Product Introduction, Application and Specification
Table Neuren Pharmaceuticals (Australia) Neuroprotective Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Neuren Pharmaceuticals (Australia) Neuroprotective Drugs Production Growth Rate (2014-2019)
Table Neuren Pharmaceuticals (Australia) Neuroprotective Drugs Production Market Share (2014-2019)
Figure Neuren Pharmaceuticals (Australia) Neuroprotective Drugs Revenue Market Share (2014-2019)
Table Neuren Pharmaceuticals (Australia) Neuroprotective Drugs Main Business and Markets Served
Table Allon therapeutics (Canada) Neuroprotective Drugs Production Sites and Area Served
Table Allon therapeutics (Canada) Neuroprotective Drugs Product Introduction, Application and Specification
Table Allon therapeutics (Canada) Neuroprotective Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Allon therapeutics (Canada) Neuroprotective Drugs Production Growth Rate (2014-2019)
Table Allon therapeutics (Canada) Neuroprotective Drugs Production Market Share (2014-2019)
Figure Allon therapeutics (Canada) Neuroprotective Drugs Revenue Market Share (2014-2019)
Table Allon therapeutics (Canada) Neuroprotective Drugs Main Business and Markets Served
Table Bionure Inc. (USA) Neuroprotective Drugs Production Sites and Area Served
Table Bionure Inc. (USA) Neuroprotective Drugs Product Introduction, Application and Specification
Table Bionure Inc. (USA) Neuroprotective Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bionure Inc. (USA) Neuroprotective Drugs Production Growth Rate (2014-2019)
Table Bionure Inc. (USA) Neuroprotective Drugs Production Market Share (2014-2019)
Figure Bionure Inc. (USA) Neuroprotective Drugs Revenue Market Share (2014-2019)
Table Bionure Inc. (USA) Neuroprotective Drugs Main Business and Markets Served
Figure Global Neuroprotective Drugs Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Neuroprotective Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Neuroprotective Drugs Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Neuroprotective Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Neuroprotective Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Neuroprotective Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Neuroprotective Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Neuroprotective Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Neuroprotective Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Neuroprotective Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Neuroprotective Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Neuroprotective Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Neuroprotective Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Neuroprotective Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Neuroprotective Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Neuroprotective Drugs by Type (2019-2025)
Table Global Consumption (K Units) of Neuroprotective Drugs by Application (2019-2025)
Table Neuroprotective Drugs Distributors List
Table Neuroprotective Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Neuroprotective Drugs  Research Assistance Research Assistance

We will be happy to help you find what you need. Please write to us:

+1-888-213-4282

sales@researchreportcenter.com